7/26/2021 9:55 am Date / Time filed with the Register of Regulations | VA.R. Document Number: R____-______ |
Virginia Register Publication Information
|
Transmittal Sheet: Response to Petition for Rulemaking
Initial Agency Notice
X
Agency Decision
Promulgating Board: | Board of Optometry |
Regulatory Coordinator: | Elaine J. Yeatts (804)367-4688 elaine.yeatts@dhp.virginia.gov |
Agency Contact: | Leslie L. Knachel Executive Director (804)597-4130 leslie.knachel@dhp.virginia.gov |
Contact Address: | Department of Health Professions 9960 Mayland Drive Suite 300 Richmond, VA 23233 |
Chapter Affected: | |
18 vac 105 - 20: | Regulations of the Virginia Board of Optometry |
Statutory Authority: |
State: Chapter 32 of Title 54.1 Federal: |
Date Petition Received | 05/06/2021 |
Petitioner | Weston Pack |
To add an investigative ophthalmic drop to the approved formulary of drugs that may
be prescribed by an optometrist
Agency Plan
In accordance with Virginia law, the petition has been filed with the Register of
Regulations and will be published on June 7, 2021. Comment on the petition may be
sent by email, regular mail or posted on the Virginia Regulatory Townhall at www.townhall.virginia.gov;
comment will be requested until July 7, 2021.
Following receipt of all comments on the petition to amend regulations, the Board
will decide whether to make any changes to the regulatory language. This matter will
be on the Board's agenda for its next meeting scheduled for July 16, 2021, and the
petitioner will be informed of the Board's decision after that meeting.
Publication Date | 06/07/2021 (comment period will also begin on this date) |
Comment End Date | 07/07/2021 |
Take no action
Agency Response Date | 07/26/2021 |
At its meeting on July 16th, the Board voted to deny the petition based on information
that the drug requested is not yet approved by the Food & Drug Administration for
the particular use in optometric practice. The Board will continue to monitor the
process and will consider the initiation of a regulatory process when FDA approval
is given.